Functional analyses however have shown that B cells of MS patients can produce less of the regulatory cytokine IL-10 but more of the pro-inflammatory GM-CSF, lymphotoxin α, TNF-α, and IL-6 [47, 51, 67, 69–71]. This evidence concerns the gene CSF2 and myeloid sarcoma.